Growth Metrics

Cytek Biosciences (CTKB) Income towards Parent Company (2020 - 2025)

Historic Income towards Parent Company for Cytek Biosciences (CTKB) over the last 6 years, with Q3 2025 value amounting to -$5.5 million.

  • Cytek Biosciences' Income towards Parent Company fell 67147.34% to -$5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.8 million, marking a year-over-year decrease of 2623.35%. This contributed to the annual value of -$6.0 million for FY2024, which is 5044.45% up from last year.
  • Per Cytek Biosciences' latest filing, its Income towards Parent Company stood at -$5.5 million for Q3 2025, which was down 67147.34% from -$5.6 million recorded in Q2 2025.
  • In the past 5 years, Cytek Biosciences' Income towards Parent Company ranged from a high of $9.6 million in Q4 2024 and a low of -$11.4 million during Q1 2025
  • Moreover, its 5-year median value for Income towards Parent Company was -$1.2 million (2021), whereas its average is -$1.9 million.
  • Data for Cytek Biosciences' Income towards Parent Company shows a peak YoY increase of 41914.16% (in 2022) and a maximum YoY decrease of 221568.63% (in 2022) over the last 5 years.
  • Over the past 5 years, Cytek Biosciences' Income towards Parent Company (Quarter) stood at -$1.2 million in 2021, then surged by 419.14% to $3.7 million in 2022, then soared by 47.18% to $5.5 million in 2023, then soared by 75.49% to $9.6 million in 2024, then tumbled by 156.95% to -$5.5 million in 2025.
  • Its Income towards Parent Company was -$5.5 million in Q3 2025, compared to -$5.6 million in Q2 2025 and -$11.4 million in Q1 2025.